|
DMXL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.904090E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.954300E-02 |
| Normal-vs-Stage2 |
8.380600E-01 |
| Normal-vs-Stage3 |
5.465600E-02 |
| Normal-vs-Stage4 |
1.04710000004005E-06 |
| Stage1-vs-Stage2 |
3.338600E-01 |
| Stage1-vs-Stage3 |
7.759000E-01 |
| Stage1-vs-Stage4 |
7.103300E-03 |
| Stage2-vs-Stage3 |
2.992600E-01 |
| Stage2-vs-Stage4 |
1.437730E-02 |
| Stage3-vs-Stage4 |
5.944300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.184500E-03 |
| Normal-vs-AfricanAmerican |
6.30930000466989E-08 |
| Normal-vs-Asian |
1.519810E-01 |
| Caucasian-vs-AfricanAmerican |
1.364180E-03 |
| Caucasian-vs-Asian |
8.910600E-01 |
| AfricanAmerican-vs-Asian |
2.487800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.579800E-04 |
| Normal-vs-Female |
1.424990E-01 |
| Male-vs-Female |
2.730000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.31429999947497E-07 |
| Normal-vs-Age(41-60Yrs) |
1.035380E-01 |
| Normal-vs-Age(61-80Yrs) |
1.555850E-03 |
| Normal-vs-Age(81-100Yrs) |
4.946200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.319950E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.226120E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.095600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.464600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.428800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.797600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.666800E-01 |
| Normal-vs-Grade 2 |
4.469400E-01 |
| Normal-vs-Grade 3 |
1.415200E-03 |
| Normal-vs-Grade 4 |
8.00929988997723E-10 |
| Grade 1-vs-Grade 2 |
5.053000E-01 |
| Grade 1-vs-Grade 3 |
8.952400E-01 |
| Grade 1-vs-Grade 4 |
5.154500E-02 |
| Grade 2-vs-Grade 3 |
1.169240E-01 |
| Grade 2-vs-Grade 4 |
2.27629999999257E-05 |
| Grade 3-vs-Grade 4 |
2.384600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.071600E-01 |
| Normal-vs-ccB subtype |
8.37470000000229E-05 |
| ccA subtype-vs-ccB subtype |
3.77300000000691E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.806200E-02 |
| Normal-vs-N1 |
1.199960E-01 |
| N0-vs-N1 |
4.001800E-01 |
|
|
